Funded Project Details - FY2021
|Title:|| Convergent Genetic and Genomic Analyses of Schizophrenia|
|Congressional District Code:
||Clinical Science R&D
|| January 2018 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Objective: To identify common and rare genetic variants that increase the risk of schizophrenia (SCZ), and to study their impact on illness risk as well as measures of morbidity in large samples. Background: Schizophrenia is a major cause of disability amongst US veterans as well as worldwide, with an annual public health burden of more than $60 billion. Recent studies have strongly supported the impact of both common and rare variants on illness risk. However, the known genetic risk factors for...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.